Versor Investments LP Buys Shares of 1,545 HCA Healthcare, Inc. $HCA

Versor Investments LP acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,545 shares of the company’s stock, valued at approximately $592,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Price T Rowe Associates Inc. MD grew its stake in HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after buying an additional 587,036 shares during the last quarter. Nuveen LLC purchased a new position in HCA Healthcare in the first quarter worth $569,217,000. Pacer Advisors Inc. grew its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Finally, Nordea Investment Management AB grew its stake in HCA Healthcare by 6.8% during the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after buying an additional 59,163 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on HCA. Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Royal Bank Of Canada boosted their target price on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Barclays boosted their price objective on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Finally, Morgan Stanley set a $425.00 price target on HCA Healthcare in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Stock Performance

NYSE:HCA opened at $471.44 on Wednesday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $478.19. The firm has a market cap of $110.31 billion, a price-to-earnings ratio of 18.22, a PEG ratio of 1.38 and a beta of 1.40. The firm’s fifty day moving average is $423.66 and its two-hundred day moving average is $389.09.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the business earned $4.90 earnings per share. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.30% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.